Related Experiment Video
Updated: Jan 7, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
t(8;21)(q23;q22), a Novel Translocation Involving the RUNX1 Gene in a Patient with Acute Myeloid Leukemia
Liang Wang1, Elizabeth Sagatys2, Hailing Zhang2
1Senior Member, Dept. of Tumor Microenvironment and Metastasis, Moffitt Cancer Center, Tampa, Florida.
Objectives:
Chromosome translocations involving the RUNX1 gene at 21q22 are recurring abnormalities in acute myeloid leukemia (AML). t(8;21)(q22;q22) is the most common translocation involving the RUNX1 gene, which is categorized as an independent type of acute leukemia in the WHO classification system. The translocation results in a frame fusion of RUNX1::RUNX1T1, which is considered to be the pathogenesis of neoplasm development. The present report describes an AML case displaying a t(8;21)(q22;q22)-like translocation by initial chromosome analysis, but subsequent FISH analysis did not show the fusion signals corresponding to the RUNX1::RUNX1T1 fusion gene. Reverse transcriptase polymerase chain reaction (RT-PCR) also failed to identify the formation of the RUNX1::RUNX1T1 fusion gene. Reassessment of chromosome analysis in light of the FISH and RT-PCR data yielded a t(8;21) (q23;q22) translocation.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells

